Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

GCTK

GlucoTrack Inc

Oct 24 • 04:00PM ET

6.60

+0.11 1.69 %

Healthcare • Medical Instruments & Supplies • USA • NASD

Peers: DXCM ABT PODD TNDM LCTX MDT SENS OSUR LOCL BBSI

Index	-	P/E	-	EPS (ttm)	-2446.08	Insider Own	11.44%	Shs Outstand	0.90M	Perf Week	-0.90%
Market Cap	6.01M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	0.81M	Perf Month	7.84%
Enterprise Value	-3.27M	PEG	-	EPS next Q	-	Inst Own	0.73%	Short Float	10.37%	Perf Quarter	-3.65%
Income	-26.77M	P/S	-	EPS this Y	-	Inst Trans	0.45%	Short Ratio	0.06	Perf Half Y	-31.25%
Sales	0.00M	P/B	0.86	EPS next Y	-	ROA	-494.92%	Short Interest	0.08M	Perf YTD	-98.53%
Book/sh	7.65	P/C	0.63	EPS next 5Y	-	ROE	-1490.95%	52W High	2928.00 -99.77%	Perf Year	-99.74%
Cash/sh	10.49	P/FCF	-	EPS past 3/5Y	-37.51% -18.33%	ROIC	-375.98%	52W Low	4.22 56.40%	Perf 3Y	-99.95%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.14% 8.29%	Perf 5Y	-99.99%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	17.38%	Oper. Margin	-	ATR (14)	0.64	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.27	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	48.03	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	3.27	EPS Q/Q	99.02%	SMA20	-6.30%	Beta	0.23	Target Price	-
Payout	-	Debt/Eq	0.04	Sales Q/Q	-	SMA50	5.46%	Rel Volume	0.03	Prev Close	6.49
Employees	11	LT Debt/Eq	0.03	Earnings	-	SMA200	-66.82%	Avg Volume	1.34M	Price	6.60
IPO	Apr 25, 2013	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	38,859	Change	1.69%

Sep-11-25 08:00AM	Glucotrack to Participate in the Q3 Virtual Investor Summit (GlobeNewswire) +5.18%
Sep-02-25 10:30AM	BC-Most Active Stocks (Associated Press Finance) +26.07%
Aug-14-25 04:05PM	Glucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Aug-06-25 08:30AM	Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology (GlobeNewswire)
Jul-31-25 08:30AM	Glucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting (GlobeNewswire)
10:30AM	Loading…
Jul-21-25 10:30AM	BC-Most Active Stocks (Associated Press Finance) +36.71%
Jul-08-25 08:30AM	Glucotrack Announces Repurchase of Series A Warrants (GlobeNewswire)
Jun-25-25 08:30AM	Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions (GlobeNewswire) +26.25%
Jun-12-25 09:05AM	Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements (GlobeNewswire) -33.81%
Jun-04-25 08:30AM	Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions (GlobeNewswire)
May-28-25 08:30AM	Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD (GlobeNewswire)
May-20-25 08:30AM	Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development (GlobeNewswire)
May-14-25 05:10PM	Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights (GlobeNewswire)
10:23AM	Glucotrack gains HREC approval for clinical study of CBGM device (Medical Device Network)
May-13-25 08:01AM	Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor (GlobeNewswire)
08:00AM	Loading…
Apr-16-25 08:00AM	Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas (GlobeNewswire)
Apr-03-25 08:01AM	Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor (GlobeNewswire) -6.59%
Mar-31-25 05:00PM	Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights (GlobeNewswire) -14.88% +28.94%
Mar-19-25 08:01AM	Glucotrack to Present First-In-Human Study Results for Continuous Blood Glucose Monitor at the 2025 International Conference on Advanced Technologies & Treatment for Diabetes (GlobeNewswire) +8.90%
Feb-26-25 08:01AM	Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member (GlobeNewswire) +5.23%
Feb-05-25 11:52AM	Glucotrack Prices $3 Million Public Offering to Fund Expansion (GuruFocus.com) -12.47%
Feb-04-25 01:44PM	Glucotrack hits trial success for direct blood measuring CGM (Medical Device Network) -28.95%
12:24PM	Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering (GlobeNewswire)
08:01AM	Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor (GlobeNewswire)
Jan-30-25 08:00AM	Glucotrack Announces Reverse Stock Split (GlobeNewswire) -24.06%
Jan-29-25 09:00AM	Glucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer (GlobeNewswire)
Jan-21-25 08:01AM	Glucotrack Announces ISO 13485:2016 Certification (GlobeNewswire) +47.23%
Jan-15-25 08:01AM	Glucotrack Strenghtens Leadership Team with Addition of Industry Veteran as Vice President of Regulatory Affairs (GlobeNewswire) -35.25%
Jan-07-25 04:05PM	Glucotrack to Present at TechBio Showcase 2025 (GlobeNewswire) -10.45%
Dec-03-24 08:30AM	GLUCOTRACK ANNOUNCES START OF ENROLLMENT FOR HUMAN CLINICAL STUDY OF CONTINUOUS BLOOD GLUCOSE MONITOR (GlobeNewswire)
04:30PM	Loading…
Nov-14-24 04:30PM	Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt (GlobeNewswire) -14.33% -12.06%
Nov-13-24 09:00AM	Glucotrack, Inc. Announces Pricing of $10.0 Million Public Offering (GlobeNewswire) -77.06%
Oct-22-24 09:00AM	GLUCOTRACK TO PRESENT AT 2024 BIOFUTURE CONFERENCE (GlobeNewswire)
Oct-01-24 09:00AM	GLUCOTRACK ANNOUNCES ORAL & POSTER PRESENTATIONS AT THE 2024 DIABETES TECHNOLOGY MEETING (GlobeNewswire)
Sep-03-24 09:00AM	JOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORS (GlobeNewswire)
Aug-27-24 09:00AM	GLUCOTRACK ANNOUNCES NEW VICE PRESIDENT OF CLINICAL OPERATIONS (GlobeNewswire)
Aug-15-24 09:00AM	Glucotrack's Innovative Blood Glucose Monitoring Concept Resonates with Patients with Diabetes, According to New Survey Presented at Association of Diabetes Care and Education Specialists (ADCES) 2024 Annual Conference (GlobeNewswire) +22.74%
Aug-05-24 09:00AM	GLUCOTRACK ANNOUNCES POSTER PRESENTATION ON CONTINUOUS BLOOD GLUCOSE MONITOR SURVEY DATA AT THE ASSOCIATION OF DIABETES CARE AND EDUCATION SPECIALISTS (ADCES) 2024 ANNUAL CONFERENCE (GlobeNewswire)
Jul-31-24 04:00PM	GLUCOTRACK ANNOUNCES NEW FUNDING FOR DEVELOPMENT OF ITS CONTINUOUS BLOOD GLUCOSE MONITOR (GlobeNewswire) -6.25% +10.00%
Jun-20-24 08:30AM	GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ANDY BALO TO BOARD OF DIRECTORS (GlobeNewswire)
Jun-13-24 09:19AM	GLUCOTRACK REPORTS SUCCESSFUL COMPLETION OF FIRST REPORTED LONG-TERM PRECLINICAL STUDY OF ITS EPIDURAL GLUCOSE MONITORING SENSOR (GlobeNewswire)
Jun-11-24 10:50AM	Sidoti Events, LLC's Virtual June Small-Cap Conference (ACCESSWIRE) -7.19%
Jun-10-24 10:50AM	GLUCOTRACK TO PRESENT IN THE JUNE 2024 SIDOTI SMALL CAP CONFERENCE (GlobeNewswire)
Jun-05-24 08:30AM	GLUCOTRACK ANNOUNCES 90-DAY PRECLINICAL STUDY RESULTS THAT DEMONSTRATE SUSTAINED ACCURACY OF ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR (GlobeNewswire)
May-17-24 02:52PM	GCTK Stock Earnings: GlucoTrack Reported Results for Q1 2024 (InvestorPlace)
May-16-24 08:30AM	GLUCOTRACK'S EPIDURAL GLUCOSE MONITORING SENSOR DEMONSTRATES SUCCESSFUL 30-DAY SAFETY & PERFORMANCE IN LONG-TERM PRECLINICAL STUDY (GlobeNewswire)
May-15-24 04:15PM	GLUCOTRACK ANNOUNCES REVERSE STOCK SPLIT (GlobeNewswire) -10.20%
May-02-24 09:00AM	GLUCOTRACK ANNOUNCES ABSTRACTS ACCEPTED FOR POSTER PRESENTATION AT 84TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION (GlobeNewswire)
Apr-29-24 07:33AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace) +23.00%
Apr-25-24 02:18AM	Director and 10% Owner Drew Sycoff Acquires 182,540 Shares of GlucoTrack Inc (GCTK) (GuruFocus.com)
Apr-22-24 02:10PM	GLUCOTRACK ANNOUNCES CLOSING OF PRIVATE PLACEMENT (GlobeNewswire) +9.88%
Apr-16-24 08:30AM	GLUCOTRACK ANNOUNCES EXPANSION OF ITS CONTINUOUS GLUCOSE MONITORING TECHNOLOGY TO EPIDURAL GLUCOSE MONITORING (GlobeNewswire) +24.93%
Apr-03-24 07:00AM	Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now (GlobeNewswire) +13.33%
Apr-02-24 08:30AM	GLUCOTRACK ANNOUNCES INCREASED SENSOR LONGEVITY FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR (GlobeNewswire) +7.46%
07:00AM	Presenting on the Emerging Growth Conference 69 Day 1 on April 3 Register Now (GlobeNewswire)
Mar-12-24 09:30AM	GLUCOTRACK EXPANDS LEADERSHIP TEAM WITH NEW VICE PRESIDENT OF QUALITY (GlobeNewswire)
Feb-27-24 08:30AM	GLUCOTRACK SELECTS CIRTEC MEDICAL AS MANUFACTURER FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR (GlobeNewswire) +13.78%
Feb-13-24 09:30AM	GLUCOTRACK ANNOUNCES THE APPOINTMENT OF LUIS MALAV TO CHAIR OF THE BOARD OF DIRECTORS (GlobeNewswire) -10.79%
Feb-07-24 07:00AM	Presenting on the Emerging Growth Conference 67 Day 2 on February 8 Register Now (GlobeNewswire) +6.28%
Feb-06-24 07:00AM	Presenting on the Emerging Growth Conference 67 Day 1 on February 7 Register Now (GlobeNewswire)
Jan-10-24 07:00AM	Presenting on Emerging Growth Conference 66 Day 2 on January 11 Register to Stream (GlobeNewswire)
Jan-09-24 07:00AM	Presenting on the Emerging Growth Conference 66 Day 1 on January 10 Register Now (GlobeNewswire)
Jan-02-24 12:33PM	GLUCOTRACK ANNOUNCES EARLY ACCURACY DATA FOR ITS IMPLANTABLE CONTINUOUS GLUCOSE MONITOR (GlobeNewswire) +8.95%
Nov-30-23 05:39PM	GLUCOTRACK ANNOUNCES 180-DAY EXTENSION TO REGAIN COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT (GlobeNewswire) +7.31% +23.40%
Nov-13-23 09:00AM	GLUCOTRACK ANNOUNCES SHAREHOLDER UPDATE (GlobeNewswire)
Oct-12-23 08:30AM	GLUCOTRACK ANNOUNCES PRECLINICAL TESTING WITH IMPLANTABLE CONTINUOUS GLUCOSE MONITOR (GlobeNewswire) -20.65%
Aug-31-23 08:30AM	GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ERIN CARTER TO BOARD OF DIRECTORS (GlobeNewswire)
Aug-28-23 09:00AM	GLUCOTRACK ANNOUNCES NEW VP OF MARKETING (GlobeNewswire)
Jul-26-23 02:30PM	The Power Play by The Market Herald Releases New Interviews with GlucoTrack and Acceleware Discussing Their Latest News (ACCESSWIRE) -7.95%
Jul-25-23 09:00AM	GLUCOTRACK ANNOUNCES POSITIVE DATA FROM FEASIBILITY STUDY FOR IMPLANTABLE CONTINUOUS GLUCOSE MONITOR (GlobeNewswire)
Apr-17-23 11:05AM	Aegis Capital Corp. Acted as Sole Bookrunner on a $10 Million Underwritten Public Offering for GlucoTrack, Inc. (NASDAQ: GCTK) (ACCESSWIRE) -7.39%
09:15AM	GlucoTrack Closes $10 Million Underwritten Public Offering of Common Stock (GlobeNewswire)
Apr-13-23 09:22AM	GlucoTrack Announces Pricing of $10 Million Underwritten Public Offering of Common Stock (GlobeNewswire) -49.26%
Apr-12-23 05:50PM	GlucoTrack Announces Proposed Underwritten Public Offering of Common Stock (GlobeNewswire) +37.76%
Mar-14-23 10:00AM	GLUCOTRACK PROVIDES SHAREHOLDER UPDATE (GlobeNewswire) +16.94%

GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements in less than one minute via a small sensor that is clipped onto one's earlobe and connected to a small, handheld control and display unit, all without drawing blood or interstitial fluid. It was designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain. The company was founded by Avner Gal and David Malka in September 2001 and is headquartered in Rutherford, NJ.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GCTK

GlucoTrack Inc

Upgrade your FINVIZ experience